Clinical Trials · NCT02716974
A Study of Definitive Therapy to Treat Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 26
- Start date
- Jun 2016
- Locations
- 3 sites, United States
- Primary endpoint
- Efficacy as Assessed by 2-year PSA Progression-free Survival Rate